Other studies, beyond the main scope of this review, aim to restore CEBPa function by blocking the CEBPa upstream suppressor RAC1 [337] or by targeting the downstream CEBPa p30 tumor-promoting targets [338]. Here, CEBPA is linked to neoplasm.